This trial is active, not recruiting.

Conditions pre-diabetes, diabetes
Sponsor Yale University
Collaborator American Heart Association
Start date October 2001
End date September 2005
Trial size 103 participants
Trial identifier NCT00589459, 12258, AHA, Donaghue Women's Health R02524


The primary goal of this study is to measure the prevalence of undiagnosed pre-diabetes/diabetes among women hospitalized with acute coronary syndromes (ACS) compared to men. Inpatients with confirmed ACS (and no known prior history of diabetes) are invited to return to the Yale Hospital Research Unit 6-8 weeks after hospital discharge for an oral glucose tolerance test to identify individuals with pre-diabetes and diabetes.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective cross-sectional
non-diabetic women with acute coronary syndrome (ACS)
non-diabetic men with acute coronary syndrome (ACS)

Primary Outcomes

Prevalence of undiagnosed pre-diabetes or undiagnosed diabetes
time frame: after hospitalization for acute coronary syndrome

Eligibility Criteria

Male or female participants at least 30 years old.

Inclusion Criteria: - acute coronary syndrome - age > 30 yrs Exclusion Criteria: - previously diagnosed diabetes - ACS due to substance abuse or trauma

Additional Information

Official title A Pilot Study of Gender Differences in the Prevalence of Undiagnosed Diabetes in Acute Coronary Syndromes (ACS)
Principal investigator Barbara I Gulanski, MD, MPH
Trial information was received from ClinicalTrials.gov and was last updated in January 2008.
Information provided to ClinicalTrials.gov by Yale University.